PeptidesMasters
Start Here
ExperimentalLongevityFat Loss

MOTS-c: What It Is, What the Research Says, and What You Need to Know

A mitochondria-derived peptide that regulates metabolism and may extend healthy lifespan

Last updated: May 1, 2026

Educational purposes only. The information on this page is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. Research peptides are not FDA-approved for human therapeutic use unless explicitly stated. Always consult a licensed healthcare provider before using any compound.

What Is MOTS-c?

MOTS-c is a recently discovered class of peptide — a mitochondrial-derived peptide (MDP) — encoded in the mitochondrial genome's 12S rRNA region. This makes it unique: unlike nuclear-encoded peptides, MOTS-c is produced by mitochondria themselves.

Discovered in 2015 by Dr. Changhan David Lee at USC, MOTS-c has rapidly attracted significant scientific interest because of its broad metabolic effects and potential role in the biology of aging.

It is one of the newest peptides in research circles with the least amount of human data — but the mechanistic data is compelling.

What Does the Research Say?

  • Animal studies demonstrate MOTS-c prevents age-related weight gain and metabolic dysfunction.
  • Research shows MOTS-c mimics some effects of exercise on metabolism — earning it the label 'exercise in a bottle' in popular science coverage.
  • Studies show improved insulin sensitivity and glucose metabolism in obese and diabetic mouse models.
  • MOTS-c levels decline with age in humans — a correlation that is actively researched.
  • No completed human clinical trials as of 2026.

Research context: Animal studies showing positive effects do not guarantee the same results in humans. Human evidence strength varies significantly by peptide — see the Quick Stats sidebar for details.

Common Use Cases in Research

These reflect how researchers and research communities discuss this compound — not therapeutic recommendations.

  • Metabolic health and insulin sensitivity research
  • Longevity and anti-aging protocols
  • Exercise performance research
  • Obesity research

How It Works (Mechanism of Action)

Activates AMPK (AMP-activated protein kinase) — the master metabolic regulator — promotes glucose metabolism, improves insulin sensitivity, and translocates to the nucleus during stress to regulate adaptive gene expression.

Reported Benefits & Risks

Reported Benefits

Improved metabolic efficiency
Potential insulin sensitizing effects
Enhanced physical performance
Possible longevity benefits

Reported Risks

Extremely limited human safety data
Research is very early-stage
Injection only (not orally bioavailable)
Unknown long-term effects

What People Ask

What makes MOTS-c different from other peptides?

MOTS-c is encoded in the mitochondrial genome — not the nuclear genome like most peptides. This makes it a truly mitochondrial-derived signal that regulates metabolism in a fundamentally different way from most other research peptides.

Legal & Regulatory Status

FDA Status

Research Only

Research chemical. Very new — no regulatory status.

Cited Research

Commonly Stacked With

Compare in the Compare Tool

Research Suppliers

Affiliate link below — we may earn a commission if you purchase. This does not influence our research coverage.

View MOTS-c Research Suppliers (affiliate link)

Related Peptides